Shaoyong Li,Ph.D.
Head of Vector Biology
Dr. Li brings over 15 years of research and development experience in AAV gene therapy, spanning capsid engineering, bioprocessing, analytical development, and preclinical studies supporting IND-enabling programs. Prior to joining Exegenesis, Dr. Li held scientific roles at leading biotechnology companies at Voyager Therapeutics and AGTC. He earned his Ph.D. in Veterinary Biomedical Sciences from China Agricultural University and completed postdoctoral training focused on AAV biology and translational research at the Gene Therapy Center of UMass Medical School. He was enrolled in the Visiting Fellows program (2008.01-2011.05) at Harvard Medical School where he conducted research on the mechanism of liver fibrosis. Dr. Li has been granted 3 patents and published 20+ articles and conference abstracts.